- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Directorate Change
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Publication of 2021 AGM Notice
AnnouncementREG - GlaxoSmithKline PLC - GSK respiratory product sales reporting changes
AnnouncementREG - GlaxoSmithKline PLC - Moncef Slaoui Departs Galvani Bioelectronics
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Chair of Audit & Risk Committee
AnnouncementREG - GlaxoSmithKline PLC - Medicago and GSK start Phase 3 trial
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Annual Report 2020 on Form 20-F
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK and Vir share positive VIR-7831 data in COVID
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Annual Financial Report
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
Announcement